Psychological distress as a negative survival factor for patients with hematologic malignancies who underwent allogeneic hematopoietic stem cell transplantation

Pharmacotherapy

Volumn 30, Issue 12, 2010, Pages 1239-1246

  Park, Ji Eun ^a   Kim, Kyung Im ^a   Yoon, Sung Soo ^b   Hahm, Bong Jin ^b   Lee, Sang Min ^a   Yoon, Jeong Hyun ^c   Shin, Wan Gyoon ^a   Lee, Hye Suk ^b   Oh, Jung Mi ^a  

^a Seoul National University   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Pusan National University   (South Korea)

Author keywords

Distress; Hematologic malignancy; Hematopoietic stem cell transplantation; Psychological stress; Survival

Indexed keywords

OPIATE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER PATIENT; CANCER RELAPSE; CANCER SURVIVAL; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DISTRESS SYNDROME; FEMALE; FOLLOW UP; HEMATOLOGIC MALIGNANCY; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYELODYSPLASTIC SYNDROME; NEUTROPHIL COUNT; NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; WHOLE BODY RADIATION;

ADULT; FEMALE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; STRESS, PSYCHOLOGICAL; TRANSPLANTATION, HOMOLOGOUS;

EID: 78650197446     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.30.12.1239     Document Type: Article

References (37)

1. Holland JC, Andersen B, Breitbart WS, et al. NCCN clinical practice guidelines in oncology: distress management. J Natl Compr Canc Netw 2007;5:66-98.
2. Harris EC, Barraclough B. Excess mortality of mental disorder. Br J Psychiatry 1998;173:11-53.
3. Black SA, Markides KS, Ray LA. Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes. Diabetes Care 2003;26:2822-8.
4. Wulsin LR, Vaillant GE, Wells VE. A systematic review of the mortality of depression. Psychosom Med 1999;61:6-17.
5. Neitzert CS, Ritvo P, Dancey J, Weiser K, Murray C, Avery J. The psychosocial impact of bone marrow transplantation: a review of the literature. Bone Marrow Transplant 1998;22:409-22. (Pubitemid 28412470)
6. Chang G, Orav EJ, McNamara T, Tong MY, Antin JH. Depression, cigarette smoking, and hematopoietic stem cell transplantation outcome. Cancer 2004;101:782-9.
7. Hoodin F, Weber S. A systematic review of psychosocial factors affecting survival after bone marrow transplantation. Psychosomatics 2003;44:181-95.
8. Loberiza FR Jr, Rizzo JD, Bredeson CN, et al. Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases. J Clin Oncol 2002;20:2118-26.
9. Prieto JM, Atala J, Blanch J, et al. Role of depression as a predictor of mortality among cancer patients after stem-cell transplantation. J Clin Oncol 2005;23:6063-71.
10. Broers S, Hengeveld MW, Kaptein AA, Le Cessie S, van de Loo F, de Vries T. Are pretransplant psychological variables related to survival after bone marrow transplantation? A prospective study of 123 consecutive patients. J Psychosom Res 1998;45:341-51. (Pubitemid 28448737)
11. Molassiotis A, Van Den Akker OB, Milligan DW, Goldman JM. Symptom distress, coping style and biological variables as predictors of survival after bone marrow transplantation. J Psychosom Res1997;42:275-85.
12. Palmer JL, Fisch MJ. Association between symptom distress and survival in outpatients seen in a palliative care cancer center. J Pain Symptom Manage 2005;29:565-71.
13. Ashbury FD, Madlensky L, Raich P, et al. Antidepressant prescribing in community cancer care. Support Care Cancer 2003;11:278-85.
14. Pirl WF, Roth AJ. Diagnosis and treatment of depression in cancer patients. Oncology (Williston Park) 1999;13:1293-301; discussion 301-2, 305-6.
15. Faris R, Purcell H, Henein MY, Coats AJ. Clinical depression is common and significantly associated with reduced survival in patients with non-ischaemic heart failure. Eur J Heart Fail 2002;4:541-51.
16. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000;160:2101-7.
17. Benzon H, Rathmell J, Wu C, Turk D, Argoff C. A Raj's practical management of pain. Maryland Heights, MO: Elsevier-Mosby, 2008.
18. Ickovics JR, Hamburger ME, Vlahov D, et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV epidemiology research study. JAMA 2001;285:1466-74.
19. Blumenthal JA, Lett HS, Babyak MA, et al. Depression as a risk factor for mortality after coronary artery bypass surgery. Lancet 2003;362:604-9.
20. Gaston-Johansson F, Franco T, Zimmerman L. Pain and psychological distress in patients undergoing autologous bone marrow transplantation. Oncol Nurs Forum 1992;19:41-8.
21. Rocha V, Labopin M, Sanz G, et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 2004;351:2276-85.
22. Barker JN, Weisdorf DJ, DeFor TE, et al. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 2005;105:1343-7.
23. Derolf AR, Kristinsson SY, Andersson TM, Landgren O, Dickman PW, Bjorkholm M. Improved patient survival for acute myeloid leukemia: a population-based study of 9,729 patients diagnosed in Sweden 1973-2005. Blood 2009;113:3666-72.
24. Slovacek L, Slovackova B, Jebavy L, Pavlik V. Quality of life in adult patients treated with peripheral blood progenitor cell transplantation: the effect of selected psychosocial, demographics and health aspects on quality of life - a retrospective analysis. Acta Medica (Hradec Kralove) 2007;50:119-24.
25. Hoodin F, Kalbfleisch KR, Thornton J, Ratanatharathorn V. Psychosocial influences on 305 adults' survival after bone marrow transplantation: depression, smoking, and behavioral self-regulation. J Psychosom Res 2004;57:145-54.
26. Chang G, Orav EJ, Tong MY, Antin JH. Predictors of 1-year survival assessed at the time of bone marrow transplantation. Psychosomatics 2004;45:378-85.
27. Stagno SJ, Busby K, Shapiro A, Kotz MM. Patients at risk: addressing addiction in patients undergoing hematopoietic SCT. Bone Marrow Transplant 2008;42:221-6.
28. Kebriaei P, Kline J, Stock W, et al. Impact of disease burden at time of allogeneic stem cell transplantation in adults with acute myeloid leukemia and myelodysplastic syndromes. Bone Marrow Transplant 2005;35:965-70.
29. Csete M. Gender Issues in transplantation. Anesth Analg 2008;107:232-8.
30. Stewart BL, Storer B, Storek J, et al. Duration of immunosuppressive treatment for chronic graft-versus-host disease. Blood 2004;104:3501-6.
31. Flomenberg N, Baxter-Lowe LA, Confer D, et al. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood 2004;104:1923-30.
32. Couriel D, Caldera H, Champlin R, Komanduri K. Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management. Cancer 2004;101:1936-46.
33. Clift RA, Buckner CD, Appelbaum FR, et al. Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens. Blood 1990;76:1867-71.
34. Kiecolt-Glaser JK, Glaser R. Depression and immune function: central pathways to morbidity and mortality. J Psychosom Res 2002;53:873-6.
35. Wagner JE, Barker JN, DeFor TE, et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002;100:1611-18.
36. Lesko L, Ostroff J, Mumma G, Mashberg D, Holland J. Longterm psychological adjustment of acute leukemia survivors: impact of bone marrow transplantation versus conventional chemotherapy. Psychosom Med 1992;54:30-47.
37. Vose JM, Kennedy BC, Bierman PJ, Kessinger A, Armitage JO. Long-term sequelae of autologous bone marrow or peripheral stem cell transplantation for lymphoid malignancies. Cancer 1992;69:784-9.